Skip to content

Clinical trials

Atrial Fibrillation trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Country / region: Singapore Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20052
20062
20074
20081
20091
20101
20111
20121
20132
20141
20151
20164
20183
20192
20201
20211
20222
20232
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated5
Unknown status5
Active, not recruiting3
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
Sanofi5
Abbott Medical Devices3
Bayer3
Boston Scientific Corporation2
Bristol-Myers Squibb2
National Heart Centre Singapore2
National University Hospital, Singapore2
Advanz Pharma1
Astellas Pharma Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation38
Stroke11
Cardiovascular Diseases4
Heart Diseases4
Heart Failure4
Arrhythmias, Cardiac3
Thromboembolism3
Atrial Flutter2
Coronary Artery Disease2
Embolism2

Trials

Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.